Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, 10700, Thailand
NCT Number: NCT03205540
This study evaluates postoperative analgesic efficacy within 48 hours between epidural analgesia and single-shot bilateral adductor canal blocks in bilateral total knee arthroplasty. Half of participants will be received continuous epidural analgesia, while other half of participants will be received single-shot bilateral adductor canal blocks.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bangkok, 10700, Thailand
Continuous epidural analgesia is effective postoperative pain control but it has some limitations in patients with hypotension, concurrent anticoagulants, technical difficulty, urinary retention.
Adductor canal block is less invasive than continuous epidural analgesia. It provides effective analgesia for total knee arthroplasty and preserves quadriceps muscle strength.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Continuous epidural block at level L2-3 or L3-4 with 0.0625% bupivacaine + fentanyl 2 mcg/ml infusion epidurally 5 ml/hr for 48 hours postoperatively.
Bilateral single-shot adductor canal blocks, ultrasound guidance, with 0.33% bupivacaine 15 ml on each side.
Time frame: 48 hours postoperatively
numerical rating scales
Time frame: 48 hours postoperatively
total miligrams of morphine use in each arm
Time frame: 48 hours postoperatively
numerical rating scales
Time frame: 48 hours postoperatively
nausea vomiting hypotension
Mahidol University
Other
Comparison Efficacy of Analgesic Techniques: Continuous Epidural Analgesia Versus Bilateral Single-shot Adductor Canal Blocks in Patients Undergoing Bilateral Total Knee Arthroplasty
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07258693
Osteo Arthritis Knee
Las Palmas de Gran Canaria, Spain
View Trial DetailsNCT06257537
Arthritis, Joint Diseases
Stamford, Connecticut, United States
View Trial DetailsNCT06965946
Arthritis, Joint Diseases
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT06084988
Osteo Arthritis Knee
Abu Dhabi, United Arab Emirates
View Trial Details